CEPI partners with Bharat Biotech, others to develop variant

The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced the latest award under its $200m programme to advance the development of vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.

Related Keywords

Australia , India , Sydney , New South Wales , Switzerland , Bharat , Richard Hatchett , James Triccas , Krishna Ella , Mariaj Wurm , Bharat Biotech International Ltd , Sydney Institute For Infectious Diseases , Coalition For Epidemic Preparedness Innovations , University Of Sydney , Epidemic Preparedness Innovations , Bharat Biotech , Managing Director , Prof James Triccas , Sydney Institute , Infectious Diseases ,